Study guide
5.4 Pharmacy Records, Retention Periods & Facility Operating Standards
Utah MPJE Pharmacy Jurisprudence Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Utah Pharmacy Regulatory Framework, Facility Licensing & the PIC
1.1 DOPL, the Utah State Board of Pharmacy & the Sources of Utah Pharmacy Law 1.2 Federal vs. Utah Law: Following the Stricter Standard 1.3 Utah Pharmacy License Classes (A–E) & Facility Licensing 1.4 The Pharmacist-in-Charge (PIC): Duties, Self-Audits & Notifications 1.5 Facility Inspections, Ownership & Location Changes, Closing & Facility Discipline
2 Chapter 2: Pharmacist, Intern & Technician Licensure and Personnel
2.1 Pharmacist Licensure, the NAPLEX & Utah MPJE, and Licensure by Endorsement 2.2 License Renewal, Continuing Education & Reinstatement 2.3 Pharmacy Interns & Preceptors 2.4 Pharmacy Technicians, Technician Trainees & Supportive Personnel
3 Chapter 3: Unlawful & Unprofessional Conduct, Discipline, and Impairment
3.1 Unlawful Conduct, Criminal Penalties, Fines & the Disciplinary Process 3.2 Unprofessional Conduct, the APhA Code of Ethics & Utah's Conscience Law 3.3 Impairment, the Utah Professionals Health Program & Reinstatement
4 Chapter 4: Prescription Issuance, Prescriber Authority & Electronic Prescribing
4.1 Prescriber Scope of Authority in Utah 4.2 Required Prescription Elements, Oral & Faxed Orders, and Alterations 4.3 Mandatory Electronic Prescribing of Controlled Substances (EPCS) in Utah 4.4 Legitimate Medical Purpose, Corresponding Responsibility & Red Flags
5 Chapter 5: Patient Counseling, Prospective DUR, Confidentiality & Records
5.1 Patient Counseling: The Offer, Who May Counsel & Delivered Prescriptions 5.2 Prospective Drug Utilization Review & Patient Medication Profiles 5.3 Confidentiality, HIPAA & Protected Health Information 5.4 Pharmacy Records, Retention Periods & Facility Operating Standards
6 Chapter 6: Expanded Practice: Collaboration, Pharmacist Prescribing & Drug Administration
6.1 Collaborative Pharmacy Practice, Drug Therapy Management & Administration of Drugs 6.2 Self-Administered Hormonal Contraception: Standing Order & Pharmacist Prescribing 6.3 Pharmacist Prescribing Under Utah Code § 58-17b-627: Tobacco Cessation, HIV PrEP/PEP, Fluoride & Epinephrine 6.4 Vaccine Administration: DOPL's Protocol, Delegation, Emergencies & USIIS Reporting
7 Chapter 7: Opioid Overdose Prevention, Emergency Refills & Returned or Donated Drugs
7.1 Naloxone & Opioid-Safety Laws in Utah 7.2 Emergency Refills, Combined Refills & Insulin Continuity 7.3 Returned Drugs, Consumer Disposal & the Charitable Prescription Drug Recycling Program
8 Chapter 8: Controlled Substance Schedules, Registration & Security in Utah
8.1 Controlled Substance Schedules: Federal CSA & Utah-Specific Scheduling 8.2 DEA Registration & Facility Licensing 8.3 Controlled Substance Storage & Physical Security
9 Chapter 9: Dispensing Controlled Substances & the Utah Controlled Substance Database
9.1 Schedule II Prescriptions: 30-Day Window, One-Month Supply, Multiple Prescriptions & the 7-Day Acute Limit 9.2 Schedule II Partial Fills, Emergency Oral Orders & Methadone Emergency Orders 9.3 Schedule III–V Prescriptions: Refill Limits, the 80% Rule & Controlled Substance Transfers 9.4 The Utah Controlled Substance Database (CSD)
10 Chapter 10: Dispensing Standards: Labeling, Substitution, Refills, Packaging, Product Integrity & OTC Products
10.1 Prescription Labels: Utah Minimum Elements, Controlled Substance & Opioid Warnings, and Special Labels 10.2 Drug Product Selection: Generic Equivalents, Therapeutically Similar Drugs & Interchangeable Biologics 10.3 Legend-Drug Prescription Validity, Refills & Transfers 10.4 Poison Prevention Packaging Act (PPPA) & Special Packaging 10.5 Drug Product Conditions That Prohibit Dispensing: Adulterated, Misbranded, Outdated, Recalled & Suspect Products 10.6 Nonprescription Products: OTC Labeling & Packaging, Pseudoephedrine, Iodine, Schedule V & Other Restricted OTC Sales
11 Chapter 11: Acquisition, Inventory, Loss, Distribution & Delivery
11.1 Ordering Schedule II Substances: DEA Form 222 & CSOS 11.2 Controlled Substance Inventories & Utah's Schedule II Perpetual Inventory 11.3 Theft, Significant Loss & Disposal of Controlled Substances 11.4 Drug Acquisition & Distribution, Office-Use Sales, and Delivering Prescriptions to Patients
12 Chapter 12: Compounding Standards, USP Chapters & Hazardous Drugs
12.1 Non-Sterile Compounding & USP <795> Standards 12.2 Sterile Compounding & USP <797> Standards 12.3 Hazardous Drug Handling & USP <800> Standards
13 Chapter 13: Institutional, Central Processing, Remote Dispensing, Specialty Outlets & Automation
13.1 Institutional Practice: Hospitals, Pharmaceutical Administration Facilities & Emergency Drug Kits 13.2 Centralized Prescription Processing, Telepharmacy & Remote Dispensing Pharmacies 13.3 Nuclear Pharmacies, Class E Outlets & Dispensing Medical Practitioners 13.4 Automated Pharmacy Systems, Quality Assurance & Pharmacy Audits
5.4 Pharmacy Records, Retention Periods & Facility Operating Standards
Key Takeaways Explain This Topic AI
Utah requires prescription files, including refill information, to be kept for at least five years and to be immediately retrievable in written or electronic form (R156-17b-612(4)).
Every controlled substance record required by law must be kept for five years, with Schedule II records separate from Schedule III–V records (R156-37-602).
A Utah pharmacy with a refrigerator or freezer for drugs must keep a daily temperature log on days of operation and retain each entry for at least three years (R156-17b-614a(3)).
A Utah pharmacy may not dispense unless a pharmacist or DMP is physically present and immediately available, except for a remote dispensing pharmacy supervised by telepharmacy (R156-17b-614a(6)).
Pharmacy self-audits and required notices are kept for two years, and CE documentation for four years after the renewal cycle ends.
Last updated: September 2026
5.4 Pharmacy Records, Retention Periods & Facility Operating Standards
Blueprint item 4.2 covers "recordkeeping ... including content, inventory, maintenance, storage, handling, and reporting," along with "non-dispensing requirements for operations of pharmacies." In Utah these requirements come mainly from R156-17b-612, -614a, -605, and -609 and R156-37-602 .
Retention periods at a glance
Record Utah retention Source
Prescription files, including refill information 5 years , immediately retrievable R156-17b-612(4); §§ 58-17b-609, -611
- Original and transferred prescriptions (legend drugs) 5 years from the last refill R156-17b-612(5)(b)
- Printed copy or retrievable record of electronic prescriptions 5 years R156-17b-613(6)
- Any controlled substance record required by law 5 years R156-37-602(3)
- Controlled substance inventories (filed separately) 5 years R156-17b-605(2)(b)–(c)
- Records of CS disposal 5 years from disposal R156-37-606(2)
- Documentation of offers to counsel 5 years , produced within 7–10 business days R156-17b-610(4)
- Record of each dispensing pharmacist's unique initials or ID code 5 years R156-17b-614a(8)
- Automated pharmacy system event and stocking records 5 years R156-17b-620(5), (9)
- Pharmacist prescribing notifications to the primary care provider 5 years R156-17b-627(1)(e)
- Refrigerator and freezer temperature logs 3 years R156-17b-614a(3)
- Pharmacy self-audit forms 2 years R156-17b-603(3)(u)
- Copies of § 58-17b-614 notices to DOPL 2 years § 58-17b-614(4)
- CE documentation 4 years after the renewal cycle R156-17b-309(5)
- Patient medication profiles 1 year after the most recent fill R156-17b-609(1)
- Hormonal contraception standing-order records 7 years DHHS statewide standing order
- Pseudoephedrine sales log 2 years after the latest entry § 58-37c-208(5)
- DEA controlled substance records (federal minimum) 2 years 21 CFR 1304.04
The general rule is five years for prescriptions and controlled substance records. The exceptions (3-year temperature logs, 2-year self-audits and notices, 4-year CE records, 1-year profiles) are common exam distractors.
Controlled substance recordkeeping (R156-37-602)
Keep records of purchase, distribution, dispensing, prescribing, and administration according to state and federal law.
Keep Schedule II records separate from other pharmacy records, and Schedule III–V records separate from other records.
Prescription records may be kept electronically if the original of each prescription, including telephone prescriptions , is kept in a physical file with the required information, and an automated system provides immediate retrieval of CIII–IV refill information under federal guidelines.
If a licensee sells or transfers records, the new owner must keep them separate from its own records.
Report theft or significant loss to DEA immediately , with a copy to DOPL, and to local law enforcement (R156-37-602(2)).
Under R156-17b-614a(9)–(14), the pharmacy must also keep copies of DEA Form 222 (properly dated, initialed, and filed), unaccepted or defective forms, any power of attorney for signing Form 222, suppliers' invoices with the date and initials of the person who verified receipt of controlled substances, suppliers' credit memos , copies of inventories (made available to DOPL on request), and hard copies of surrender or destruction reports .
Temperature control (R156-17b-614a(3))
The pharmacy's temperature must be kept within a range compatible with proper drug storage.
If the pharmacy uses a refrigerator or freezer to store drugs, it must keep a daily written or electronic log of its temperature on days of operation , and keep each log entry for at least three years .
For reference, USP storage ranges are 20–25 °C for controlled room temperature, 2–8 °C for refrigeration, and −25 to −10 °C for freezing. Document excursions and follow manufacturer stability guidance before dispensing affected stock.
Delivered prescriptions must travel in packaging that maintains appropriate temperatures, following manufacturer or USP <1079> recommendations (R156-17b-608(1)(a)).
General operating standards for Class A and B pharmacies (R156-17b-614a)
Standard Requirement
Physical plant Well lighted, ventilated, clean, and sanitary. A sink with hot and cold culinary water , separate from restroom facilities, if drugs are transferred from original containers. Cleanrooms may not have sinks or floor drains.
Storage Orderly storage that permits clear identification and retrieval, in an environment that maintains product integrity
Security A pharmacy that dispenses controlled substances needs a security system that detects entry when closed and notifies an individual. The pharmacy must have a lock and be securely locked when closed . With a drop ceiling and no locked drug cabinet, walls must reach the hard deck or other measures must prevent entry.
Counseling A counseling area that allows confidential counseling, if applicable
References Current Utah pharmacy and controlled substance statutes and rules (58-1, R156-1, 58-17b, R156-17b, 58-37, R156-37, 58-37f, R156-37f), 21 CFR 1300 et seq. or equivalent, the FDA Approved Drug Products list, and other needed references, in print or electronic form
Staff list A current list of licensed employees with names, license classifications, license numbers, and expiration dates, readily retrievable for DOPL
Pharmacist presence No dispensing unless a pharmacist or DMP is physically present and immediately available . A remote dispensing pharmacy may instead be supervised through a telepharmacy system.
After-hours access Only a licensed Utah pharmacist, DMP, or authorized personnel (pharmacy staff who take part in the pharmacy's operations) may access the pharmacy when it is closed
Pharmacist identification A 5-year record of each dispensing pharmacist's unique initials or ID code
Compounded prescription labels have extra requirements (R156-17b-614a(2)). See Section 10.1.
Scenario
An inspector finds that a pharmacy discarded its refrigerator logs after 12 months, keeps Schedule II invoices mixed with general invoices, and dispensed prescriptions for 20 minutes while the only pharmacist was away from the store. The logs violate the three-year rule, the invoices violate R156-37-602(5), and the dispensing violates R156-17b-614a(6).